Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065654705> ?p ?o ?g. }
- W2065654705 endingPage "48" @default.
- W2065654705 startingPage "40" @default.
- W2065654705 abstract "Growth factors such as bone morphogenetic protein-2 (BMP-2) have been proven to promote spine fusion and to overcome the disadvantages of an autologous bone graft. The optimum method to deliver such growth factors remains a matter of discussion. The purpose of this study was to determine the safety and efficacy of a new poly(D,L-lactide) (PDLLA) carrier system for BMP-2 and to compare this carrier system with a collagen sponge carrier in a sheep cervical spine interbody fusion model.Thirty-two sheep underwent C3-4 discectomy and fusion: Group 1, titanium cage (eight animals); Group 2, titanium cage coated with a PDLLA carrier (eight animals); Group 3, titanium cage coated with a PDLLA carrier including BMP-2 (150 microg) (eight animals); and Group 4, titanium cage combined with a collagen sponge carrier including BMP-2 (150 microg) (eight animals). Blood samples, body weight, and temperature were assessed. Radiographs were obtained pre- and postoperatively and after 1, 2, 4, 8, and 12 weeks. At the same time points, disc space height, intervertebral angle, and lordosis angle were measured. After the sheep were killed 12 weeks postoperatively, flexion-extension radiography was performed to evaluate fusion sites. Quantitative computerized tomography scans were obtained to assess bone mineral density (BMD), bone mineral content (BMC), and bone callus volume (BCV). Biomechanical testing was performed in flexion, extension, axial rotation, and lateral bending. Stiffness, range of motion, neutral, and elastic zone were determined. Histomorphological and -morphometrical analyses were performed, and polychrome sequential labeling was used to determine the timeframe of new bone formation. There were no differences among the groups concerning blood counts, body weight, and temperature. Compared with the noncoated cages, all PDLLA-coated cages showed significantly higher values for BMD of the callus, as well as slightly higher values for BMC, BCV, and the bone volume/total volume ratio. In comparison with the cage-alone group, the BMP-2 groups showed significantly higher values for BMD and biomechanical stiffness. Histomorphological, -morphometrical, and polychrome sequential labeling analyses demonstrated greater progression of callus formation in the BMP-2 groups than in any other group. Compared with BMP-2 delivered using a collagen sponge carrier, BMP-2 application with a PDLLA carrier resulted in a higher BCV and a greater progression of interbody callus formation in the histomorphometrical analysis.The use of cervical spine interbody fusion cages coated with PDLLA as a delivery system for growth factors was effective. In this 12-week follow-up study, the PDLLA coating showed no adverse effects. The slight but not significant positive effect of the PDLLA carrier on interbody fusion might be a result of the degradation process of the biodegradable carrier. Compared with collagen sponge delivery of BMP-2, the PDLLA-coated interbody cages significantly increased the results of interbody bone matrix formation. In this new combination (implant + PDLLA + growth factor) the cage represents a real fusion cage, because it not only serves as a mechanical device for spinal fixation but also as a local drug delivery system." @default.
- W2065654705 created "2016-06-24" @default.
- W2065654705 creator A5010772908 @default.
- W2065654705 creator A5026329327 @default.
- W2065654705 creator A5040300499 @default.
- W2065654705 creator A5044386414 @default.
- W2065654705 creator A5047640521 @default.
- W2065654705 creator A5056289588 @default.
- W2065654705 creator A5063790209 @default.
- W2065654705 creator A5072367585 @default.
- W2065654705 creator A5074968931 @default.
- W2065654705 creator A5077205298 @default.
- W2065654705 creator A5079184013 @default.
- W2065654705 date "2002-07-01" @default.
- W2065654705 modified "2023-09-27" @default.
- W2065654705 title "Bone morphogenetic protein—2 application by a poly(d,l-lactide)—coated interbody cage: in vivo results of a new carrier for growth factors" @default.
- W2065654705 cites W1257300127 @default.
- W2065654705 cites W1747761114 @default.
- W2065654705 cites W1963908464 @default.
- W2065654705 cites W1969612347 @default.
- W2065654705 cites W1990073207 @default.
- W2065654705 cites W1990816910 @default.
- W2065654705 cites W1999884560 @default.
- W2065654705 cites W2010318332 @default.
- W2065654705 cites W2017645052 @default.
- W2065654705 cites W2023022601 @default.
- W2065654705 cites W2039523608 @default.
- W2065654705 cites W2040480316 @default.
- W2065654705 cites W2048567398 @default.
- W2065654705 cites W2049720842 @default.
- W2065654705 cites W2052414043 @default.
- W2065654705 cites W2057067590 @default.
- W2065654705 cites W2067713290 @default.
- W2065654705 cites W2072624182 @default.
- W2065654705 cites W2077042278 @default.
- W2065654705 cites W2079446801 @default.
- W2065654705 cites W2079548431 @default.
- W2065654705 cites W2093905104 @default.
- W2065654705 cites W2094488964 @default.
- W2065654705 cites W2134968806 @default.
- W2065654705 cites W2167082167 @default.
- W2065654705 cites W2312852841 @default.
- W2065654705 cites W2317015923 @default.
- W2065654705 cites W2329018393 @default.
- W2065654705 cites W2329998643 @default.
- W2065654705 cites W2332399223 @default.
- W2065654705 cites W2335725215 @default.
- W2065654705 cites W4232479820 @default.
- W2065654705 cites W4361868630 @default.
- W2065654705 doi "https://doi.org/10.3171/spi.2002.97.1.0040" @default.
- W2065654705 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12120650" @default.
- W2065654705 hasPublicationYear "2002" @default.
- W2065654705 type Work @default.
- W2065654705 sameAs 2065654705 @default.
- W2065654705 citedByCount "24" @default.
- W2065654705 countsByYear W20656547052012 @default.
- W2065654705 countsByYear W20656547052013 @default.
- W2065654705 countsByYear W20656547052015 @default.
- W2065654705 countsByYear W20656547052017 @default.
- W2065654705 countsByYear W20656547052019 @default.
- W2065654705 countsByYear W20656547052021 @default.
- W2065654705 countsByYear W20656547052022 @default.
- W2065654705 crossrefType "journal-article" @default.
- W2065654705 hasAuthorship W2065654705A5010772908 @default.
- W2065654705 hasAuthorship W2065654705A5026329327 @default.
- W2065654705 hasAuthorship W2065654705A5040300499 @default.
- W2065654705 hasAuthorship W2065654705A5044386414 @default.
- W2065654705 hasAuthorship W2065654705A5047640521 @default.
- W2065654705 hasAuthorship W2065654705A5056289588 @default.
- W2065654705 hasAuthorship W2065654705A5063790209 @default.
- W2065654705 hasAuthorship W2065654705A5072367585 @default.
- W2065654705 hasAuthorship W2065654705A5074968931 @default.
- W2065654705 hasAuthorship W2065654705A5077205298 @default.
- W2065654705 hasAuthorship W2065654705A5079184013 @default.
- W2065654705 hasBestOaLocation W20656547051 @default.
- W2065654705 hasConcept C104317684 @default.
- W2065654705 hasConcept C114614502 @default.
- W2065654705 hasConcept C126838900 @default.
- W2065654705 hasConcept C136229726 @default.
- W2065654705 hasConcept C141071460 @default.
- W2065654705 hasConcept C142724271 @default.
- W2065654705 hasConcept C160272327 @default.
- W2065654705 hasConcept C191897082 @default.
- W2065654705 hasConcept C192562407 @default.
- W2065654705 hasConcept C202751555 @default.
- W2065654705 hasConcept C2776008035 @default.
- W2065654705 hasConcept C2776541429 @default.
- W2065654705 hasConcept C2776886416 @default.
- W2065654705 hasConcept C2777825092 @default.
- W2065654705 hasConcept C2778414984 @default.
- W2065654705 hasConcept C2780375110 @default.
- W2065654705 hasConcept C2781411149 @default.
- W2065654705 hasConcept C2781430139 @default.
- W2065654705 hasConcept C2985379065 @default.
- W2065654705 hasConcept C2989005 @default.
- W2065654705 hasConcept C30352789 @default.
- W2065654705 hasConcept C31507581 @default.
- W2065654705 hasConcept C33923547 @default.